{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03252340",
      "OrgStudyIdInfo": {
        "OrgStudyId": "AD-CP-17-1"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "30902",
            "SecondaryIdType": "Other Grant/Funding Number",
            "SecondaryIdDomain": "Republic or Korea Ministry of Food and Drug Safety"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "EHL Bio Co., Ltd.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis",
      "OfficialTitle": "Observational Study to Evaluate the Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis"
    },
    "StatusModule": {
      "StatusVerifiedDate": "January 2022",
      "OverallStatus": "Active, not recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "September 19, 2017",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "August 16, 2022",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "August 16, 2022",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "August 8, 2017",
      "StudyFirstSubmitQCDate": "August 15, 2017",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "August 17, 2017",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "January 10, 2022",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 12, 2022",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "EHL Bio Co., Ltd.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "This study aims to evaluate safety in subjects with over moderately subacute and chronic atopic dermatitis after an intravenous injection of ADSTEM Inj. Since this is an observational study of patients participated in Phase 1 clinical trials, no drug is administered in this study.",
      "DetailedDescription": "Participants will be followed-up for adverse events on each visit. Visits will be on 6, 12, 18, 24, 30, 36, 48, 60months after treatment of ADSTEM Inj.\n\nTime perspective is both retrospective and prospective."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Atopic Dermatitis"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Observational",
      "PatientRegistry": "No",
      "DesignInfo": {
        "DesignObservationalModelList": {
          "DesignObservationalModel": [
            "Case-Only"
          ]
        },
        "DesignTimePerspectiveList": {
          "DesignTimePerspective": [
            "Other"
          ]
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "11",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Drug: ADSTEM Inj.",
            "ArmGroupDescription": "Participants in Phase I clinical trials treated with ADSTEM Inj.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: ADSTEM Inj."
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Drug",
            "InterventionName": "ADSTEM Inj.",
            "InterventionDescription": "ADSTEM Inj. 1.0x10^8 mesenchymal stem cells as an intravenous infusion once in Phase I clinical trial.\nADSTEM Inj. 3.0x10^8 mesenchymal stem cells as an intravenous infusion once in Phase I clinical trial.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Drug: ADSTEM Inj."
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Tumor formation",
            "PrimaryOutcomeDescription": "The number of subjects with treatment-related tumor formation",
            "PrimaryOutcomeTimeFrame": "60months after treatment of ADSTEM Inj."
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Adverse events",
            "SecondaryOutcomeDescription": "The number of subjects with treatment-related adverse events",
            "SecondaryOutcomeTimeFrame": "60months after treatment of ADSTEM Inj."
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatients who participated in Phase I clinical trials\nPatients who voluntarily agreed to participate in the study\n\nExclusion Criteria:\n\nPatients who can not follow-up from the end of the phase 1 clinical trial to the end of the study",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "19 Years",
      "MaximumAge": "70 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      },
      "StudyPopulation": "Patients who participated in Phase I clinical trials",
      "SamplingMethod": "Non-Probability Sample"
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Young-joon Seo, M.D, Ph.D",
            "OverallOfficialAffiliation": "Chungnam National University Hospital",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Chungnam National University Hospital",
            "LocationCity": "Daejeon",
            "LocationState": "Chungcheongnam-do",
            "LocationCountry": "Korea, Republic of"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000003876",
            "ConditionMeshTerm": "Dermatitis, Atopic"
          },
          {
            "ConditionMeshId": "D000003872",
            "ConditionMeshTerm": "Dermatitis"
          },
          {
            "ConditionMeshId": "D000004485",
            "ConditionMeshTerm": "Eczema"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000012871",
            "ConditionAncestorTerm": "Skin Diseases"
          },
          {
            "ConditionAncestorId": "D000012873",
            "ConditionAncestorTerm": "Skin Diseases, Genetic"
          },
          {
            "ConditionAncestorId": "D000030342",
            "ConditionAncestorTerm": "Genetic Diseases, Inborn"
          },
          {
            "ConditionAncestorId": "D000017443",
            "ConditionAncestorTerm": "Skin Diseases, Eczematous"
          },
          {
            "ConditionAncestorId": "D000006969",
            "ConditionAncestorTerm": "Hypersensitivity, Immediate"
          },
          {
            "ConditionAncestorId": "D000006967",
            "ConditionAncestorTerm": "Hypersensitivity"
          },
          {
            "ConditionAncestorId": "D000007154",
            "ConditionAncestorTerm": "Immune System Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M6223",
            "ConditionBrowseLeafName": "Dermatitis, Atopic",
            "ConditionBrowseLeafAsFound": "Atopic Dermatitis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M6219",
            "ConditionBrowseLeafName": "Dermatitis",
            "ConditionBrowseLeafAsFound": "Dermatitis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M6807",
            "ConditionBrowseLeafName": "Eczema",
            "ConditionBrowseLeafAsFound": "Atopic Dermatitis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14826",
            "ConditionBrowseLeafName": "Skin Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14828",
            "ConditionBrowseLeafName": "Skin Diseases, Genetic",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M22839",
            "ConditionBrowseLeafName": "Genetic Diseases, Inborn",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M18864",
            "ConditionBrowseLeafName": "Skin Diseases, Eczematous",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9170",
            "ConditionBrowseLeafName": "Hypersensitivity",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9172",
            "ConditionBrowseLeafName": "Hypersensitivity, Immediate",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9352",
            "ConditionBrowseLeafName": "Immune System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC16",
            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC20",
            "ConditionBrowseBranchName": "Immune System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}